Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: A meta-analysis

World Journal of Gastroenterology

Volumn 17, Issue 17, 2011, Pages 2248-2254

  Xin, Yong Ning ^a   Lin, Zhong Hua ^a   Jiang, Xiang Jun ^a   Zhan, Shu Hui ^a   Dong, Quan Jiang ^a   Wang, Qing ^a   Xuan, Shi Ying ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Human leukocyte antigen DQB1 alleles; Meta analysis

Indexed keywords

HLA DQB1 ANTIGEN;

ARTICLE; CANCER RISK; GENE FREQUENCY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR TYPING; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 79955834597     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i17.2248     Document Type: Article

References (24)

1. Schütte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis 2009; 27: 80-92
2. Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin Gastroenterol Hepatol 2008; 6: 268-274
3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576
4. Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000; 343: 702-709
5. Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000; 343: 782-786
6. Conn VS, Rantz MJ. Research methods: managing primary study quality in meta-analyses. Res Nurs Health 2003; 26: 322-333
7. Huwiler-Müntener K, Jüni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002; 287: 2801-2804
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
10. Li PK, Leung NW, Poon AS, Wong KC, Chan TH, Lai KN. Molecular genetics of major histocompatibility complex class II genes in hepatocellular carcinoma. Dig Dis Sci 1995; 40: 1542-1546
11. Donaldson PT, Ho S, Williams R, Johnson PJ. HLA class II al-leles in Chinese patients with hepatocellular carcinoma. Liver 2001; 21: 143-148
12. De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Maz-zaro C, Cannizzaro R, Dolcetti R, Boiocchi M. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profle of major histocompatibility complex class II alleles. Hum Immunol 2004; 65: 1397-404
13. López-Vázquez A, Rodrigo L, Miña-Blanco A, Martínez-Borra J, Fuentes D, Rodríguez M, Pérez R, González S, López-Larrea C. Extended human leukocyte antigen haplotype EH18.1 infuences progression to hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2004; 189: 957-963
14. Liu C, Cheng B. Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese. Int J Immunogenet 2007; 34: 373-378
15. El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest 2008; 37: 661-674
16. Pan HF. Association of gene polymorphism and expression of human leukocyte antigen-DRB1, DQB1 with hepatocellular carcinoma. JiLin: JiLin University, 2009
17. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. Hepatology 2000; 31: 819-827
18. Baccar Harrath A, Yacoubi Loueslati B, Troudi W, Hmida S, Sedkaoui S, Dridi A, Jridi A, Ben Ayed F, Ben Rhomdhane K, Ben Ammar Elgaaied A. HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathol Oncol Res 2006; 12: 79-81
19. Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS. Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia. Mol Med 1995; 1: 161-171
20. Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol 1996; 107: 373-376
21. Wu MS, Hsieh RP, Huang SP, Chang YT, Lin MT, Chang MC, Shun CT, Sheu JC, Lin JT. Association of HLA-DQB1*0301 and HLA-DQB1*0602 with different subtypes of gastric cancer in Taiwan. Jpn J Cancer Res 2002; 93: 404-410
22. Quintero E, Pizarro MA, Rodrigo L, Piqué JM, Lanas A, Ponce J, Miño G, Gisbert J, Jurado A, Herrero MJ, Jiménez A, Torrado J, Ponte A, Díaz-de-Rojas F, Salido E. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population. Helicobacter 2005; 10: 12-21
23. Ozdemir E, Kakehi Y, Mishina M, Ogawa O, Okada Y, Ozdemir D, Yoshida O. High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma. Br J Cancer 1997; 76: 1348-1352
24. Jäger D, Jäger E, Knuth A. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 2001; 54: 669-674